New IBD diagnosis · Condition program

New IBD diagnosis, a steady start on therapy.

Guides patients through the first months after an ulcerative colitis or IBD diagnosis: starting therapy, keeping up with labs and preventive care, and knowing when to call.

  • 12 weeks
  • Base · free for providers
  • Pro · patient upgrade

What’s included

Everything in the program, Base and Pro.

For: Adults newly diagnosed with ulcerative colitis or IBD-unclassified. Patients with Crohn’s disease join the Crohn’s program.

What New IBD diagnosis includes, by tier
Included in the programBaseFree to referProPatient upgrade
IBD explained: inflammation, remission and treating to targetIncludedIncluded
Guides to the prescribed therapy: how to take it and what to reportIncludedIncluded
A preventive care checklist: vaccines, bone health and skin checksIncludedIncluded
FAQs and AI Q&A from practice-approved contentIncludedIncluded
Escalation of red-flag symptoms to your practiceIncludedIncluded
Progress updates to your practiceIncludedIncluded
Daily symptom tracking with flare-risk coachingNot includedIncluded
Medication adherence support and refill remindersNot includedIncluded
Lab and infusion reminders with proactive follow-upNot includedIncluded
Diet, sleep and stress habit buildingNot includedIncluded
Thesis NP support between visitsNot includedIncluded

Program goals

  • Understand IBD, the treatment plan and the goal of remission
  • Start therapy and stay on it
  • Keep up with labs, infusions and preventive care
  • Recognize a flare early and reach the practice fast

Who acts on escalations

  • Base: red flags go straight back to your practice, with the patient’s report and context.
  • Pro: Thesis nurse practitioners can also step in, and your practice is kept informed.
  • Agents never diagnose, prescribe or change a treatment plan.

How it engages patients

One stage at a time, always on protocol.

Over 12 weeks, each stage sends the right information at the right moment, answers questions from your practice’s guidance and records what your team needs to know.

EmailWeek 0 · Base

Welcome and diagnosis explainedWhat IBD is, what remission means and the plan the patient’s clinician set.

Care teamWelcome to your IBD program. This guide explains ulcerative colitis, what remission means and the treatment plan your GI team has chosen.

RecordedEducation delivered · IBD basics read

Clinical foundation

Guideline-based care, adapted to your practice.

Program content is built on published guidelines and reviewed by our clinical team. Your practice’s own protocols always take precedence.

  1. Treat to target

    STRIDE-II sets clinical response and remission as short-term targets and endoscopic healing as a long-term goal. Education frames therapy around these targets, so patients understand why feeling better is not the finish line.

    [3] STRIDE-II 2021
  2. Timely, effective therapy

    AGA and ACG guidelines support early use of advanced therapies for appropriate patients with moderate to severe ulcerative colitis. The program explains the prescribed plan and supports adherence, but never changes therapy.

    [1] AGA 2020[2] ACG 2019
  3. Preventive care from the start

    ACG preventive care guidance covers vaccination (ideally before immunosuppression), bone health, skin cancer screening, and screening for depression and anxiety. The program turns this into a checklist for the practice to review.

    [4] ACG 2017
  4. Early flare recognition

    Patients learn the signs of a flare and report them early, so the practice can reassess before symptoms become severe.

    [2] ACG 2019

When we escalate to your practice

  • Rising stool frequency or urgency over several days
  • New or increasing blood in the stool
  • Six or more bloody stools a day
  • Fever, severe abdominal pain or a swollen abdomen
  • Dizziness or signs of dehydration
  • Signs of infection while on immunosuppressive therapy
  • Missed doses, or stopping medication

What your practice receives

  • Confirmation when the patient enrolls
  • Progress summaries at key milestones and before follow-up visits
  • Real-time escalation for any red-flag symptom
  • Pro status, so you know when Thesis nurse practitioners are supporting a patient

Sources

  1. 1American Gastroenterological AssociationFeuerstein JD, Isaacs KL, Schneider Y, et al. AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis. Gastroenterology. 2020;158(5):1450–1461.
  2. 2American College of GastroenterologyRubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD. ACG Clinical Guideline: Ulcerative Colitis in Adults. Am J Gastroenterol. 2019;114(3):384–413.
  3. 3International Organization for the Study of IBDTurner D, Ricciuto A, Lewis A, et al. STRIDE-II: an update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD). Gastroenterology. 2021;160(5):1570–1583.
  4. 4American College of GastroenterologyFarraye FA, Melmed GY, Lichtenstein GR, Kane SV. ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease. Am J Gastroenterol. 2017;112(2):241–258.

Guidelines inform program defaults. They do not replace clinical judgment, and patients are always directed to their own care team for diagnosis and treatment decisions.

Get started

You refer. We follow through.